Hightower 6M Holding’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$6.48M Sell
147,996
-18,482
-11% -$898K 0.58% 24
2022
Q2
$8.73M Sell
166,478
-2,067
-1% -$105K 0.73% 20
2022
Q1
$8.73M Buy
+168,545
New +$8.75M 0.67% 22

Other funds holding PFE

Hightower 6M Holding's PFE Position: Q3 2022 in Review

Hightower 6M Holding reduced its Pfizer (PFE) stake by 11% in Q3 2022, selling an estimated $898K and leaving 147,996 shares worth $6.48M. The position accounts for 0.58% of the portfolio, ranked #24.

Hightower 6M Holding first reported a position in PFE in Q1 2022 and has held it in 3 quarters since. The position peaked at $8.73M in Q2 2022. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Hightower 6M Holding held 147,996 shares of Pfizer worth $6.48M as of Q3 2022.
  • Hightower 6M Holding sold 18,482 Pfizer shares in Q3 2022, an estimated $898K.
  • Pfizer made up 0.58% of Hightower 6M Holding's portfolio in Q3 2022, its #24 holding.
  • Hightower 6M Holding first reported a position in Pfizer in Q1 2022 and has held it in 3 quarters since.
  • Hightower 6M Holding's Pfizer position peaked at $8.73M in Q2 2022.
  • 3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.